GB9624905D0 - MNGEF and homologues thereof - Google Patents

MNGEF and homologues thereof

Info

Publication number
GB9624905D0
GB9624905D0 GBGB9624905.7A GB9624905A GB9624905D0 GB 9624905 D0 GB9624905 D0 GB 9624905D0 GB 9624905 A GB9624905 A GB 9624905A GB 9624905 D0 GB9624905 D0 GB 9624905D0
Authority
GB
United Kingdom
Prior art keywords
mngef
homologues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9624905.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GBGB9624905.7A priority Critical patent/GB9624905D0/en
Publication of GB9624905D0 publication Critical patent/GB9624905D0/en
Priority to CA002274143A priority patent/CA2274143A1/en
Priority to JP52444898A priority patent/JP2001505424A/en
Priority to AU51302/98A priority patent/AU5130298A/en
Priority to EP97945992A priority patent/EP0941326A1/en
Priority to PCT/GB1997/003302 priority patent/WO1998023743A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB9624905.7A 1996-11-29 1996-11-29 MNGEF and homologues thereof Pending GB9624905D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9624905.7A GB9624905D0 (en) 1996-11-29 1996-11-29 MNGEF and homologues thereof
CA002274143A CA2274143A1 (en) 1996-11-29 1997-12-01 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof
JP52444898A JP2001505424A (en) 1996-11-29 1997-12-01 Mouse guanine nucleotide exchange factor (MNGEF) and its human homolog
AU51302/98A AU5130298A (en) 1996-11-29 1997-12-01 Murine guanine nucleotide exchange factor - (MNGEF) and human homologues th ereof
EP97945992A EP0941326A1 (en) 1996-11-29 1997-12-01 Murine guanine nucleotide exchange factor (mngef) and human homologues thereof
PCT/GB1997/003302 WO1998023743A1 (en) 1996-11-29 1997-12-01 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9624905.7A GB9624905D0 (en) 1996-11-29 1996-11-29 MNGEF and homologues thereof

Publications (1)

Publication Number Publication Date
GB9624905D0 true GB9624905D0 (en) 1997-01-15

Family

ID=10803710

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9624905.7A Pending GB9624905D0 (en) 1996-11-29 1996-11-29 MNGEF and homologues thereof

Country Status (6)

Country Link
EP (1) EP0941326A1 (en)
JP (1) JP2001505424A (en)
AU (1) AU5130298A (en)
CA (1) CA2274143A1 (en)
GB (1) GB9624905D0 (en)
WO (1) WO1998023743A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6340575B1 (en) 1997-06-17 2002-01-22 Onyx Pharmaceuticals, Inc. Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
WO2004096199A2 (en) * 2003-05-02 2004-11-11 Scottish Biomedical Limited Regulation of guanine nucleotide exchange factor

Also Published As

Publication number Publication date
AU5130298A (en) 1998-06-22
EP0941326A1 (en) 1999-09-15
WO1998023743A1 (en) 1998-06-04
JP2001505424A (en) 2001-04-24
CA2274143A1 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
EP1021185A4 (en) Didhydropyrimidines and uses thereof
ZA9711141B (en) Novel ketobenzamides and their use
EP0894807A4 (en) GPIb-LIPID COMPLEX AND USES THEREOF
GB9620390D0 (en) Substances and their uses
HUP0003077A3 (en) Modified factor vii
EP1037635A4 (en) Compounds and methods
GB9625899D0 (en) Substances and their uses
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
ZA96428B (en) P-heteroatom-substituted phenols and uses thereof
GB9601107D0 (en) Pallet and pallet system
DE59704086D1 (en) Twin-dualmode-filter
HK1021117A1 (en) Candy-toy and method thereof
PL331523A1 (en) Azolotrizines and azolopyrimidines
GB9609339D0 (en) Device and assembly
GB2315463B (en) Tags and components thereof
PL328334A1 (en) Preparation and application thereof
EP0998578A4 (en) Sel-10 AND USES THEREOF
GB9623539D0 (en) Enzymes and their use
HUP9900068A3 (en) Fuse-switch and/or fuse-disconnector
GB9624905D0 (en) MNGEF and homologues thereof
PL341293A1 (en) Beta-lypothropin and application thereof
GB9616563D0 (en) Compounds and methods
ZA959512B (en) Aryloxycycloalkenyl and aryloxyiminocycloalkenylhy-droxyureas
EP0934345A4 (en) Compounds and methods
GB9609498D0 (en) Aqua-saucer and aqua-vase